ScreenerHero
SHCSotera Health Company
NAS · US · Healthcare · Diagnostics & Research · soterahealth.com
19.07USD+0.37%Mkt Cap: 5.42B $P/E: 33.33

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segment…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap5.42B $
Enterprise Value7.40B $
Revenue (TTM)1.22B $
Gross Profit645.53M $
Net Income (TTM)77.95M $
Revenue/Share4.271 USD
Last Price19.07 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)33.33
P/E (Forward)17.88
PEG1.31
EV/EBITDA12.83
EV/Revenue6.08
P/S4.51
P/B8.24
EPS (TTM)0.58
EPS (Forward)1.07
52W Range
13.0988% of range19.85
52W High19.85 USD
52W Low13.09 USD
Profitability
Gross Margin55.48%
Oper. Margin37.96%
EBITDA Margin47.41%
Profit Margin6.70%
ROE12.86%
ROA2.39%
Growth
Revenue Growth9.20%
Earnings Growth569.50%
Cash Flow & Leverage
Operating CF287.19M $
CapEx (TTM)138.02M $
FCF Margin12.66%
FCF Yield2.84%
Net Debt1.91B $
Net Debt/EBITDA3.31
Balance Sheet
Debt/Equity3.75
Current Ratio2.80
Quick Ratio2.40
Book Value/Sh2.333 USD
Cash/Share1.251 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.72 USD
Upside (mean)+19.2%
Target Range18.00 USD – 25.00 USD
$18.00+19.2% to mean$25.00
# Analysts9
Ownership
Shares Out.285.37M
Float184.78M
Insiders2.31%
Institutions107.08%
Short Interest
Short Ratio4.9d
Short % Float5.82%
Short % Out.5.04%
Shares Short14.38M
Short (prev mo.)16.02M
Technical
SMA 5017.68 (+7.9%)
SMA 20016.64 (+14.6%)
Beta1.77
S&P 52W Chg18.16%
Avg Vol (30d)3.01M
Avg Vol (10d)3.27M
Technical Indicators
RSI (14)64.6
MACD0.4402
MACD Signal0.4152
MACD Hist.+0.0250
BB Upper19.61 USD
BB Middle18.25 USD
BB Lower16.88 USD
BB Width15.01%
ATR (14)0.5132 USD
Vol Ratio (20d)0.85x